COVID-19 pandemic: the beginning, the end and the path to recovery

Arnav Pushkar; Monica Sharma; Shiwali Bisht; Pranav Bhaskar

doi:10.52679/tabcj.2021.0002

Authors

Arnav Pushkar School of Physical Sciences, Jawahar Lal Nehru University, New Delhi, Delhi-110067, India
Monica Sharma Rastrapati Bhawan Cabinet Affair Apartments, Sector-10, Dwarka, New Delhi, Delhi-110075, India
Shiwali Bisht Aarogyam Medical College and Hospital, Bhagwanpur, Uttarakhand - 247661, India
Pranav Bhaskar Department of Biochemistry, Panjab University, Chandigarh - 160014, India https://orcid.org/0000-0001-7449-7222

DOI:

https://doi.org/10.52679/tabcj.2021.0002

Keywords:

coronavirus disease, COVID-19 pandemic, equitable vaccine allocation, herd immunity, vaccine

Abstract

The coronavirus disease 2019 or COVID-19 pandemic is the nastiest public health, economic, and societal crisis of our lifetime. When this global emergency hit, our entire institution quickly pivoted to deliver the actionable science that decision-makers need in times of crisis. The steps taken at the beginning of this crisis to solve the immediate, dayto-day challenges posed by the pandemic and eventually rebuild a healthier, more robust and resilient nation and world. Ensuring strong demand for and endorsing acceptance of the COVID-19 vaccines is crucial to accomplishing herd immunity, shielding the most vulnerable populations, and reopening social and economic life. This perspective article highlights the importance of equitable vaccine allocation and public engagement, and message delivery strategies to ensure demand and promote acceptance.